AGALSIDASE BETA

7468 reported adverse events

Drug classes: Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]

These side effects are most commonly reported by patients taking AGALSIDASE BETA:

# Side effect Count
0 PYREXIA 448
1 CHILLS 428
2 PAIN 424
3 MALAISE 403
4 NAUSEA 389
5 DYSPNOEA 348
6 FATIGUE 317
7 VOMITING 312
8 HEADACHE 310
9 INFUSION RELATED REACTION 277
See all common reactions for AGALSIDASE BETA

AGALSIDASE BETA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GLOBOTRIAOSYLCERAMIDE INCREASED 46 1.0000
1 GLOBOTRIAOSYLSPHINGOSINE INCREASED 40 0.9756
2 RENAL TRANSPLANT 67 0.0236
3 DRUG SPECIFIC ANTIBODY PRESENT 91 0.0182
4 RENAL FAILURE CHRONIC 85 0.0110
5 INFUSION SITE EXTRAVASATION 54 0.0100
6 POOR VENOUS ACCESS 56 0.0073
7 END STAGE RENAL DISEASE 119 0.0071
8 INFUSION RELATED REACTION 277 0.0056
9 TRANSIENT ISCHAEMIC ATTACK 132 0.0045
See all enriched reactions for AGALSIDASE BETA